nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—Emotional distress—Metformin—polycystic ovary syndrome	0.0157	0.132	CcSEcCtD
Bepridil—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0113	0.0952	CcSEcCtD
Bepridil—TNNC1—adrenal cortex—polycystic ovary syndrome	0.00859	0.0262	CbGeAlD
Bepridil—TNNC1—endometrium—polycystic ovary syndrome	0.00767	0.0234	CbGeAlD
Bepridil—CACNA1A—adrenal gland—polycystic ovary syndrome	0.00742	0.0226	CbGeAlD
Bepridil—PDE1B—adipose tissue—polycystic ovary syndrome	0.00721	0.022	CbGeAlD
Bepridil—KCNQ1—adrenal cortex—polycystic ovary syndrome	0.00698	0.0213	CbGeAlD
Bepridil—TNNC1—pituitary gland—polycystic ovary syndrome	0.00694	0.0212	CbGeAlD
Bepridil—TNNC1—adipose tissue—polycystic ovary syndrome	0.00692	0.0211	CbGeAlD
Bepridil—PDE1B—adrenal gland—polycystic ovary syndrome	0.00647	0.0197	CbGeAlD
Bepridil—TNNC1—adrenal gland—polycystic ovary syndrome	0.0062	0.0189	CbGeAlD
Bepridil—PDE1A—uterus—polycystic ovary syndrome	0.00618	0.0189	CbGeAlD
Bepridil—CYP2D6—urine—polycystic ovary syndrome	0.00613	0.0187	CbGeAlD
Bepridil—PDE1A—adipose tissue—polycystic ovary syndrome	0.00604	0.0185	CbGeAlD
Bepridil—CACNA2D2—pituitary gland—polycystic ovary syndrome	0.00584	0.0178	CbGeAlD
Bepridil—KCNQ1—pituitary gland—polycystic ovary syndrome	0.00564	0.0172	CbGeAlD
Bepridil—KCNQ1—adipose tissue—polycystic ovary syndrome	0.00562	0.0172	CbGeAlD
Bepridil—PDE1B—endocrine gland—polycystic ovary syndrome	0.00561	0.0171	CbGeAlD
Bepridil—PDE1A—adrenal gland—polycystic ovary syndrome	0.00542	0.0165	CbGeAlD
Bepridil—CACNA2D2—adrenal gland—polycystic ovary syndrome	0.00522	0.0159	CbGeAlD
Bepridil—PDE1A—female gonad—polycystic ovary syndrome	0.00506	0.0154	CbGeAlD
Bepridil—KCNQ1—adrenal gland—polycystic ovary syndrome	0.00504	0.0154	CbGeAlD
Bepridil—CACNA1D—adrenal cortex—polycystic ovary syndrome	0.00484	0.0148	CbGeAlD
Bepridil—CACNA2D2—vagina—polycystic ovary syndrome	0.00484	0.0148	CbGeAlD
Bepridil—CACNA1H—uterus—polycystic ovary syndrome	0.00482	0.0147	CbGeAlD
Bepridil—CACNA1H—pituitary gland—polycystic ovary syndrome	0.00474	0.0145	CbGeAlD
Bepridil—PDE1A—endocrine gland—polycystic ovary syndrome	0.0047	0.0144	CbGeAlD
Bepridil—KCNQ1—female gonad—polycystic ovary syndrome	0.0047	0.0143	CbGeAlD
Bepridil—CACNA2D2—endocrine gland—polycystic ovary syndrome	0.00453	0.0138	CbGeAlD
Bepridil—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00447	0.0375	CcSEcCtD
Bepridil—KCNQ1—endocrine gland—polycystic ovary syndrome	0.00437	0.0133	CbGeAlD
Bepridil—CACNA1H—adrenal gland—polycystic ovary syndrome	0.00423	0.0129	CbGeAlD
Bepridil—Influenza—Metformin—polycystic ovary syndrome	0.00418	0.0351	CcSEcCtD
Bepridil—Angina pectoris—Metformin—polycystic ovary syndrome	0.00408	0.0342	CcSEcCtD
Bepridil—ATP1A1—embryo—polycystic ovary syndrome	0.00407	0.0124	CbGeAlD
Bepridil—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00401	0.0337	CcSEcCtD
Bepridil—CACNA1H—female gonad—polycystic ovary syndrome	0.00395	0.012	CbGeAlD
Bepridil—CACNA1D—pituitary gland—polycystic ovary syndrome	0.00391	0.0119	CbGeAlD
Bepridil—CALM3—adrenal cortex—polycystic ovary syndrome	0.00374	0.0114	CbGeAlD
Bepridil—Drowsiness—Metformin—polycystic ovary syndrome	0.00373	0.0313	CcSEcCtD
Bepridil—CACNA1H—endocrine gland—polycystic ovary syndrome	0.00367	0.0112	CbGeAlD
Bepridil—CACNA1C—pituitary gland—polycystic ovary syndrome	0.00361	0.011	CbGeAlD
Bepridil—CACNA1C—adipose tissue—polycystic ovary syndrome	0.0036	0.011	CbGeAlD
Bepridil—CALM2—embryo—polycystic ovary syndrome	0.00359	0.0109	CbGeAlD
Bepridil—CALM1—embryo—polycystic ovary syndrome	0.00357	0.0109	CbGeAlD
Bepridil—CACNA1D—adrenal gland—polycystic ovary syndrome	0.00349	0.0107	CbGeAlD
Bepridil—Bradycardia—Metformin—polycystic ovary syndrome	0.00341	0.0286	CcSEcCtD
Bepridil—Rhinitis—Metformin—polycystic ovary syndrome	0.00336	0.0282	CcSEcCtD
Bepridil—CALM3—endometrium—polycystic ovary syndrome	0.00334	0.0102	CbGeAlD
Bepridil—ATP1A1—adrenal cortex—polycystic ovary syndrome	0.00334	0.0102	CbGeAlD
Bepridil—CACNA1C—adrenal gland—polycystic ovary syndrome	0.00323	0.00984	CbGeAlD
Bepridil—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00311	0.0261	CcSEcCtD
Bepridil—CALM3—uterus—polycystic ovary syndrome	0.00308	0.0094	CbGeAlD
Bepridil—CACNA1D—endocrine gland—polycystic ovary syndrome	0.00303	0.00925	CbGeAlD
Bepridil—CALM3—pituitary gland—polycystic ovary syndrome	0.00302	0.00923	CbGeAlD
Bepridil—CALM3—adipose tissue—polycystic ovary syndrome	0.00301	0.00919	CbGeAlD
Bepridil—CACNA1C—vagina—polycystic ovary syndrome	0.00299	0.00912	CbGeAlD
Bepridil—ATP1A1—endometrium—polycystic ovary syndrome	0.00298	0.0091	CbGeAlD
Bepridil—CALM2—adrenal cortex—polycystic ovary syndrome	0.00294	0.00897	CbGeAlD
Bepridil—CALM1—adrenal cortex—polycystic ovary syndrome	0.00293	0.00893	CbGeAlD
Bepridil—Flatulence—Metformin—polycystic ovary syndrome	0.00287	0.0241	CcSEcCtD
Bepridil—CACNA1C—endocrine gland—polycystic ovary syndrome	0.0028	0.00854	CbGeAlD
Bepridil—Vision blurred—Metformin—polycystic ovary syndrome	0.00275	0.0231	CcSEcCtD
Bepridil—ATP1A1—uterus—polycystic ovary syndrome	0.00275	0.00838	CbGeAlD
Bepridil—Tremor—Metformin—polycystic ovary syndrome	0.00273	0.0229	CcSEcCtD
Bepridil—CALM3—adrenal gland—polycystic ovary syndrome	0.0027	0.00825	CbGeAlD
Bepridil—ATP1A1—pituitary gland—polycystic ovary syndrome	0.0027	0.00823	CbGeAlD
Bepridil—ATP1A1—adipose tissue—polycystic ovary syndrome	0.00269	0.0082	CbGeAlD
Bepridil—CALM2—endometrium—polycystic ovary syndrome	0.00262	0.00801	CbGeAlD
Bepridil—Syncope—Metformin—polycystic ovary syndrome	0.00261	0.0219	CcSEcCtD
Bepridil—CALM1—endometrium—polycystic ovary syndrome	0.00261	0.00797	CbGeAlD
Bepridil—Palpitations—Metformin—polycystic ovary syndrome	0.00258	0.0216	CcSEcCtD
Bepridil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00256	0.0215	CcSEcCtD
Bepridil—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.00256	0.297	CrCbGaD
Bepridil—CALM3—female gonad—polycystic ovary syndrome	0.00252	0.00769	CbGeAlD
Bepridil—Hypertension—Metformin—polycystic ovary syndrome	0.00252	0.0211	CcSEcCtD
Bepridil—CALM3—vagina—polycystic ovary syndrome	0.0025	0.00764	CbGeAlD
Bepridil—Myalgia—Metformin—polycystic ovary syndrome	0.00248	0.0208	CcSEcCtD
Bepridil—CALM2—uterus—polycystic ovary syndrome	0.00242	0.00738	CbGeAlD
Bepridil—ATP1A1—adrenal gland—polycystic ovary syndrome	0.00241	0.00735	CbGeAlD
Bepridil—CALM1—uterus—polycystic ovary syndrome	0.00241	0.00735	CbGeAlD
Bepridil—Oedema—Metformin—polycystic ovary syndrome	0.00238	0.02	CcSEcCtD
Bepridil—KCNH2—endometrium—polycystic ovary syndrome	0.00238	0.00726	CbGeAlD
Bepridil—CALM2—pituitary gland—polycystic ovary syndrome	0.00237	0.00725	CbGeAlD
Bepridil—CALM2—adipose tissue—polycystic ovary syndrome	0.00236	0.00722	CbGeAlD
Bepridil—CALM1—pituitary gland—polycystic ovary syndrome	0.00236	0.00722	CbGeAlD
Bepridil—CALM1—adipose tissue—polycystic ovary syndrome	0.00235	0.00719	CbGeAlD
Bepridil—Shock—Metformin—polycystic ovary syndrome	0.00234	0.0196	CcSEcCtD
Bepridil—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0023	0.0193	CcSEcCtD
Bepridil—Anorexia—Metformin—polycystic ovary syndrome	0.00227	0.019	CcSEcCtD
Bepridil—ATP1A1—female gonad—polycystic ovary syndrome	0.00225	0.00686	CbGeAlD
Bepridil—ATP1A1—vagina—polycystic ovary syndrome	0.00223	0.00681	CbGeAlD
Bepridil—KCNH2—uterus—polycystic ovary syndrome	0.00219	0.00669	CbGeAlD
Bepridil—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.00218	0.253	CrCbGaD
Bepridil—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00217	0.0182	CcSEcCtD
Bepridil—KCNH2—pituitary gland—polycystic ovary syndrome	0.00215	0.00657	CbGeAlD
Bepridil—Paraesthesia—Metformin—polycystic ovary syndrome	0.00214	0.0179	CcSEcCtD
Bepridil—CALM2—adrenal gland—polycystic ovary syndrome	0.00212	0.00648	CbGeAlD
Bepridil—Dyspnoea—Metformin—polycystic ovary syndrome	0.00212	0.0178	CcSEcCtD
Bepridil—Somnolence—Metformin—polycystic ovary syndrome	0.00212	0.0177	CcSEcCtD
Bepridil—CALM1—adrenal gland—polycystic ovary syndrome	0.00211	0.00645	CbGeAlD
Bepridil—Dyspepsia—Metformin—polycystic ovary syndrome	0.00209	0.0176	CcSEcCtD
Bepridil—ATP1A1—endocrine gland—polycystic ovary syndrome	0.00209	0.00638	CbGeAlD
Bepridil—Decreased appetite—Metformin—polycystic ovary syndrome	0.00207	0.0174	CcSEcCtD
Bepridil—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00205	0.0172	CcSEcCtD
Bepridil—Constipation—Metformin—polycystic ovary syndrome	0.00203	0.0171	CcSEcCtD
Bepridil—CALM2—female gonad—polycystic ovary syndrome	0.00198	0.00604	CbGeAlD
Bepridil—CALM1—female gonad—polycystic ovary syndrome	0.00197	0.00601	CbGeAlD
Bepridil—CALM2—vagina—polycystic ovary syndrome	0.00197	0.006	CbGeAlD
Bepridil—CALM1—vagina—polycystic ovary syndrome	0.00196	0.00597	CbGeAlD
Bepridil—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00195	0.0163	CcSEcCtD
Bepridil—KCNH2—adrenal gland—polycystic ovary syndrome	0.00192	0.00587	CbGeAlD
Bepridil—Abdominal pain—Metformin—polycystic ovary syndrome	0.00188	0.0158	CcSEcCtD
Bepridil—CALM2—endocrine gland—polycystic ovary syndrome	0.00184	0.00562	CbGeAlD
Bepridil—CALM1—endocrine gland—polycystic ovary syndrome	0.00183	0.00559	CbGeAlD
Bepridil—KCNH2—female gonad—polycystic ovary syndrome	0.00179	0.00547	CbGeAlD
Bepridil—KCNH2—vagina—polycystic ovary syndrome	0.00178	0.00544	CbGeAlD
Bepridil—Asthenia—Metformin—polycystic ovary syndrome	0.00171	0.0143	CcSEcCtD
Bepridil—KCNH2—endocrine gland—polycystic ovary syndrome	0.00167	0.00509	CbGeAlD
Bepridil—Diarrhoea—Metformin—polycystic ovary syndrome	0.00163	0.0137	CcSEcCtD
Bepridil—Dizziness—Metformin—polycystic ovary syndrome	0.00157	0.0132	CcSEcCtD
Bepridil—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00154	0.178	CrCbGaD
Bepridil—Rash—Metformin—polycystic ovary syndrome	0.0015	0.0126	CcSEcCtD
Bepridil—Dermatitis—Metformin—polycystic ovary syndrome	0.0015	0.0126	CcSEcCtD
Bepridil—Headache—Metformin—polycystic ovary syndrome	0.00149	0.0125	CcSEcCtD
Bepridil—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.00147	0.17	CrCbGaD
Bepridil—ABCB1—embryo—polycystic ovary syndrome	0.00142	0.00435	CbGeAlD
Bepridil—Nausea—Metformin—polycystic ovary syndrome	0.00141	0.0119	CcSEcCtD
Bepridil—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00117	0.00356	CbGeAlD
Bepridil—CYP2D6—female gonad—polycystic ovary syndrome	0.00109	0.00334	CbGeAlD
Bepridil—ABCB1—endometrium—polycystic ovary syndrome	0.00104	0.00318	CbGeAlD
Bepridil—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00102	0.0031	CbGeAlD
Bepridil—ABCB1—uterus—polycystic ovary syndrome	0.000961	0.00293	CbGeAlD
Bepridil—ABCB1—pituitary gland—polycystic ovary syndrome	0.000944	0.00288	CbGeAlD
Bepridil—ABCB1—adipose tissue—polycystic ovary syndrome	0.00094	0.00287	CbGeAlD
Bepridil—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.000874	0.101	CrCbGaD
Bepridil—ABCB1—adrenal gland—polycystic ovary syndrome	0.000843	0.00257	CbGeAlD
Bepridil—ABCB1—female gonad—polycystic ovary syndrome	0.000786	0.0024	CbGeAlD
Bepridil—ABCB1—vagina—polycystic ovary syndrome	0.000781	0.00238	CbGeAlD
Bepridil—ABCB1—endocrine gland—polycystic ovary syndrome	0.000731	0.00223	CbGeAlD
Bepridil—CALM2—Signaling Pathways—FGF18—polycystic ovary syndrome	3.3e-05	6.06e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TCF7L2—polycystic ovary syndrome	3.3e-05	6.05e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TCF7L2—polycystic ovary syndrome	3.3e-05	6.05e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKR1C3—polycystic ovary syndrome	3.27e-05	6.01e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKR1C3—polycystic ovary syndrome	3.27e-05	6.01e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RBP4—polycystic ovary syndrome	3.27e-05	6.01e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RBP4—polycystic ovary syndrome	3.27e-05	6.01e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT2—polycystic ovary syndrome	3.27e-05	6.01e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT2—polycystic ovary syndrome	3.27e-05	6.01e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT2—polycystic ovary syndrome	3.25e-05	5.96e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	3.24e-05	5.95e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SLC2A4—polycystic ovary syndrome	3.24e-05	5.95e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SLC2A4—polycystic ovary syndrome	3.24e-05	5.95e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP17A1—polycystic ovary syndrome	3.22e-05	5.92e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP17A1—polycystic ovary syndrome	3.22e-05	5.92e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.22e-05	5.92e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.22e-05	5.92e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.22e-05	5.9e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.21e-05	5.9e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PRL—polycystic ovary syndrome	3.2e-05	5.87e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—YAP1—polycystic ovary syndrome	3.16e-05	5.8e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT2—polycystic ovary syndrome	3.14e-05	5.77e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT2—polycystic ovary syndrome	3.14e-05	5.77e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	3.14e-05	5.77e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GAB1—polycystic ovary syndrome	3.12e-05	5.72e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PRL—polycystic ovary syndrome	3.09e-05	5.68e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PRL—polycystic ovary syndrome	3.09e-05	5.68e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	3.07e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.06e-05	5.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.06e-05	5.61e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.05e-05	5.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.01e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.01e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INSR—polycystic ovary syndrome	2.98e-05	5.47e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.97e-05	5.45e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—BCL2—polycystic ovary syndrome	2.95e-05	5.43e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL18—polycystic ovary syndrome	2.91e-05	5.35e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.89e-05	5.31e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—TH—polycystic ovary syndrome	2.88e-05	5.29e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INSR—polycystic ovary syndrome	2.88e-05	5.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INSR—polycystic ovary syndrome	2.88e-05	5.29e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.86e-05	5.26e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—BCL2—polycystic ovary syndrome	2.86e-05	5.25e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—BCL2—polycystic ovary syndrome	2.86e-05	5.25e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NRG1—polycystic ovary syndrome	2.85e-05	5.23e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.83e-05	5.2e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL18—polycystic ovary syndrome	2.82e-05	5.17e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL18—polycystic ovary syndrome	2.82e-05	5.17e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—SLC2A4—polycystic ovary syndrome	2.8e-05	5.15e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.8e-05	5.14e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—TH—polycystic ovary syndrome	2.79e-05	5.12e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—TH—polycystic ovary syndrome	2.79e-05	5.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.79e-05	5.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PGR—polycystic ovary syndrome	2.76e-05	5.07e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NRG1—polycystic ovary syndrome	2.75e-05	5.06e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NRG1—polycystic ovary syndrome	2.75e-05	5.06e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.75e-05	5.05e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.74e-05	5.03e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.74e-05	5.03e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.72e-05	4.99e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—SLC2A4—polycystic ovary syndrome	2.71e-05	4.98e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—SLC2A4—polycystic ovary syndrome	2.71e-05	4.98e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.7e-05	4.95e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.7e-05	4.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.7e-05	4.95e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.69e-05	4.94e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—IL6—polycystic ovary syndrome	2.68e-05	4.92e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NCOR1—polycystic ovary syndrome	2.68e-05	4.92e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PGR—polycystic ovary syndrome	2.67e-05	4.9e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PGR—polycystic ovary syndrome	2.67e-05	4.9e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP19A1—polycystic ovary syndrome	2.64e-05	4.84e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NRG1—polycystic ovary syndrome	2.63e-05	4.83e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—IL6—polycystic ovary syndrome	2.59e-05	4.76e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—IL6—polycystic ovary syndrome	2.59e-05	4.76e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.59e-05	4.76e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NCOR1—polycystic ovary syndrome	2.59e-05	4.76e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NCOR1—polycystic ovary syndrome	2.59e-05	4.76e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.57e-05	4.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PLAT—polycystic ovary syndrome	2.56e-05	4.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GHRL—polycystic ovary syndrome	2.56e-05	4.71e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.56e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP19A1—polycystic ovary syndrome	2.55e-05	4.68e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP19A1—polycystic ovary syndrome	2.55e-05	4.68e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NRG1—polycystic ovary syndrome	2.54e-05	4.67e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NRG1—polycystic ovary syndrome	2.54e-05	4.67e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.53e-05	4.64e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.48e-05	4.56e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.48e-05	4.56e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GHRL—polycystic ovary syndrome	2.48e-05	4.56e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PLAT—polycystic ovary syndrome	2.48e-05	4.56e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.46e-05	4.51e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—polycystic ovary syndrome	2.46e-05	4.51e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—VEGFA—polycystic ovary syndrome	2.46e-05	4.51e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ATF1—polycystic ovary syndrome	2.45e-05	4.49e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IRS2—polycystic ovary syndrome	2.44e-05	4.48e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CRP—polycystic ovary syndrome	2.44e-05	4.48e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.42e-05	4.44e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.39e-05	4.38e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.38e-05	4.37e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—VEGFA—polycystic ovary syndrome	2.38e-05	4.36e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—VEGFA—polycystic ovary syndrome	2.38e-05	4.36e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.37e-05	4.35e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.37e-05	4.35e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MTHFR—polycystic ovary syndrome	2.37e-05	4.35e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IRS2—polycystic ovary syndrome	2.36e-05	4.33e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IRS2—polycystic ovary syndrome	2.36e-05	4.33e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CRP—polycystic ovary syndrome	2.36e-05	4.33e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CRP—polycystic ovary syndrome	2.36e-05	4.33e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GNAS—polycystic ovary syndrome	2.35e-05	4.32e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.31e-05	4.24e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.31e-05	4.24e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.3e-05	4.22e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MTHFR—polycystic ovary syndrome	2.29e-05	4.2e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MTHFR—polycystic ovary syndrome	2.29e-05	4.2e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GNAS—polycystic ovary syndrome	2.28e-05	4.18e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GNAS—polycystic ovary syndrome	2.28e-05	4.18e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—polycystic ovary syndrome	2.27e-05	4.16e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.26e-05	4.15e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IRS2—polycystic ovary syndrome	2.25e-05	4.13e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—polycystic ovary syndrome	2.25e-05	4.13e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.24e-05	4.12e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NCOR1—polycystic ovary syndrome	2.24e-05	4.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PRL—polycystic ovary syndrome	2.24e-05	4.11e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—TH—polycystic ovary syndrome	2.19e-05	4.01e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.18e-05	4.01e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.18e-05	4.01e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IRS2—polycystic ovary syndrome	2.18e-05	4e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IRS2—polycystic ovary syndrome	2.18e-05	4e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.17e-05	3.98e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.17e-05	3.98e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NCOR1—polycystic ovary syndrome	2.17e-05	3.98e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NCOR1—polycystic ovary syndrome	2.17e-05	3.98e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PRL—polycystic ovary syndrome	2.16e-05	3.97e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PRL—polycystic ovary syndrome	2.16e-05	3.97e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.16e-05	3.96e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IRS1—polycystic ovary syndrome	2.13e-05	3.91e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	2.13e-05	3.9e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP1A1—polycystic ovary syndrome	2.13e-05	3.9e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.12e-05	3.9e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.1e-05	3.86e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.09e-05	3.83e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.09e-05	3.83e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—polycystic ovary syndrome	2.07e-05	3.81e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TH—polycystic ovary syndrome	2.06e-05	3.78e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IRS1—polycystic ovary syndrome	2.06e-05	3.78e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IRS1—polycystic ovary syndrome	2.06e-05	3.78e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP1A1—polycystic ovary syndrome	2.06e-05	3.78e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP1A1—polycystic ovary syndrome	2.06e-05	3.78e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.05e-05	3.77e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.05e-05	3.77e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2e-05	3.68e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2e-05	3.67e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MTHFR—polycystic ovary syndrome	1.98e-05	3.64e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT2—polycystic ovary syndrome	1.97e-05	3.62e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GNAS—polycystic ovary syndrome	1.97e-05	3.61e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IRS1—polycystic ovary syndrome	1.97e-05	3.61e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MTHFR—polycystic ovary syndrome	1.92e-05	3.52e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MTHFR—polycystic ovary syndrome	1.92e-05	3.52e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT2—polycystic ovary syndrome	1.91e-05	3.5e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT2—polycystic ovary syndrome	1.91e-05	3.5e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.9e-05	3.5e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.9e-05	3.5e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IRS1—polycystic ovary syndrome	1.9e-05	3.49e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IRS1—polycystic ovary syndrome	1.9e-05	3.49e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.88e-05	3.46e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—INS—polycystic ovary syndrome	1.88e-05	3.46e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.87e-05	3.44e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NRG1—polycystic ovary syndrome	1.84e-05	3.38e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—INS—polycystic ovary syndrome	1.82e-05	3.34e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—INS—polycystic ovary syndrome	1.82e-05	3.34e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT2—polycystic ovary syndrome	1.82e-05	3.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.81e-05	3.33e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.81e-05	3.33e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.78e-05	3.28e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.78e-05	3.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.78e-05	3.27e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT2—polycystic ovary syndrome	1.76e-05	3.23e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT2—polycystic ovary syndrome	1.76e-05	3.23e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SERPINE1—polycystic ovary syndrome	1.73e-05	3.17e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—BCL2—polycystic ovary syndrome	1.72e-05	3.16e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.7e-05	3.12e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.68e-05	3.09e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SERPINE1—polycystic ovary syndrome	1.67e-05	3.07e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SERPINE1—polycystic ovary syndrome	1.67e-05	3.07e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—BCL2—polycystic ovary syndrome	1.66e-05	3.06e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—BCL2—polycystic ovary syndrome	1.66e-05	3.06e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.61e-05	2.96e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARG—polycystic ovary syndrome	1.61e-05	2.95e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.6e-05	2.94e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.59e-05	2.92e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—POMC—polycystic ovary syndrome	1.58e-05	2.91e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.58e-05	2.89e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—INS—polycystic ovary syndrome	1.58e-05	2.89e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARG—polycystic ovary syndrome	1.55e-05	2.85e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARG—polycystic ovary syndrome	1.55e-05	2.85e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LEP—polycystic ovary syndrome	1.54e-05	2.83e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—POMC—polycystic ovary syndrome	1.53e-05	2.82e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—POMC—polycystic ovary syndrome	1.53e-05	2.82e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—polycystic ovary syndrome	1.53e-05	2.81e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.52e-05	2.8e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.52e-05	2.8e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—INS—polycystic ovary syndrome	1.52e-05	2.8e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—INS—polycystic ovary syndrome	1.52e-05	2.8e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.52e-05	2.79e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.5e-05	2.76e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LEP—polycystic ovary syndrome	1.49e-05	2.74e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LEP—polycystic ovary syndrome	1.49e-05	2.74e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—polycystic ovary syndrome	1.48e-05	2.72e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—polycystic ovary syndrome	1.48e-05	2.72e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.45e-05	2.67e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.42e-05	2.6e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.38e-05	2.53e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.33e-05	2.44e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.33e-05	2.44e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—POMC—polycystic ovary syndrome	1.33e-05	2.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INS—polycystic ovary syndrome	1.32e-05	2.42e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—POMC—polycystic ovary syndrome	1.28e-05	2.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—POMC—polycystic ovary syndrome	1.28e-05	2.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INS—polycystic ovary syndrome	1.27e-05	2.34e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INS—polycystic ovary syndrome	1.27e-05	2.34e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.27e-05	2.34e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.27e-05	2.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.23e-05	2.26e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.23e-05	2.26e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.23e-05	2.26e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.23e-05	2.26e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.22e-05	2.24e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.21e-05	2.22e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.2e-05	2.21e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.19e-05	2.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.17e-05	2.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.17e-05	2.15e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.15e-05	2.11e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.13e-05	2.08e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.13e-05	2.07e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—polycystic ovary syndrome	9.75e-06	1.79e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.43e-06	1.73e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—polycystic ovary syndrome	9.43e-06	1.73e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—polycystic ovary syndrome	8.91e-06	1.64e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—polycystic ovary syndrome	8.62e-06	1.58e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—polycystic ovary syndrome	8.62e-06	1.58e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.33e-06	1.53e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—polycystic ovary syndrome	8.22e-06	1.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.05e-06	1.48e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.05e-06	1.48e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—polycystic ovary syndrome	7.95e-06	1.46e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—polycystic ovary syndrome	7.95e-06	1.46e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—polycystic ovary syndrome	5.76e-06	1.06e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—polycystic ovary syndrome	5.57e-06	1.02e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—polycystic ovary syndrome	5.57e-06	1.02e-05	CbGpPWpGaD
